Ghost Tree Capital, LLC Incyte Corp Transaction History

Ghost Tree Capital, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$60.95 - $75.51 $609,500 - $755,100	-10,000 Reduced 13.33%	65,000 $4.05 Million
Q1 2023 May 15, 2023	BUY	$70.23 - $86.01 $5.27 Million - $6.45 Million	75,000 New	75,000 $5.42 Million
Q4 2017 Feb 14, 2018	BUY	$93.56 - $116.6 $1.4 Million - $1.75 Million	15,000 Added 42.86%	50,000 $4.74 Million
Q3 2017 Nov 14, 2017	BUY	$109.15 - $138.27 $3.82 Million - $4.84 Million	35,000	35,000 $4.09 Million

644

186M

714K

557K

Ticker INCY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 222,431,008
Market Cap $16.6B
Description
Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...

Get notified when there are updates to the investment portfolio of Ghost Tree Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Ghost Tree Capital, LLC with notifications on news.